Youwen Si

Youwen Si

Auto-generated profile, based on publicly available information

Youwen Si

Key Laboratory of Brain Functional Genomics, Ministry of Education, School of Life Sciences, East China Normal University, Shanghai, China

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

14 August 2025 in Journal of Alzheimer’s Disease
Verified
Journal Article
Closed access
YSYouwen Si
Youwen Si
SQShuai Qiu
Shuai Qiu
LWLina Wang
Lina Wang
BMBo Meng
Bo Meng
Background: Nicotine's complex physiological effects vary significantly between healthy and neurodegenerative states, yet the underlying metabolic mechanisms remain poorly understood. Objective: To investigate the differential metabolic responses to chronic nicotine administration in healthy versus neurodegenerative conditions and elucidate the underlying biochemical pathways that govern these genotype-dependent effects. Methods: Eight-month-old presenilin-1/2 double knockout (DKO) mice and wild-type (WT) controls underwent three-month oral nicotine administration (100 μg/mL). We assessed body weight, spontaneous locomotor activity via open field testing, and conducted comprehensive metabolomic analyses using untargeted LC-MS and GC-MS. Results: Nicotine administration did not significantly affect body weight or locomotor activity in either genotype. In LC-MS, DKO-B mice showed dysregulation in purine metabolism, amino acid pathways, mTOR signaling, and lipolysis compared to WT-B mice. DKO mice showed disruptions in steroid hormone biosynthesis and Fc gamma R-mediated phagocytosis, suggest altered stress responses and immune dysfunction after nicotine administration. In WT mice, distinct changes in amino acid metabolism and drug interaction pathways were observed. In GC-MS, Central carbon metabolism emerged as the most enriched pathway in DKO-B versus WT-B mice. WT-N enrichments included the TCA cycle, cholesterol metabolism, and amino acid pathways, while DKO-N changes involved branched-chain amino acid metabolism, ketone body metabolism, and the pentose phosphate pathway. Conclusions: Chronic nicotine elicits distinct metabolic responses in healthy versus neurodegenerative conditions. These genotype-specific effects highlight nicotine's potential as a personalized therapeutic agent and metabolic modulator in neurodegenerative disease.

1 November 2024 in Current Alzheimer Research
Verified
Journal Article
Closed access
PDF file
YSYouwen Si
Youwen Si
BMBo Meng
Bo Meng
FQFeiyan Qi
Feiyan Qi
Introduction: The potential therapeutic role of nicotine in Alzheimer's disease (AD) remains controversial, particularly regarding its age-dependent effects and underlying mechanisms. Methods: This study investigated the impact of chronic nicotine administration on cognitive function and molecular pathways in Presenilin 1/2 double knockout (DKO) mice, an amyloid-β (Aβ)- independent model of AD. Three-month-old and eight-month-old DKO and wild-type (WT) mice received oral nicotine treatment (100 μg/ml) for three months. Behavioral assessments revealed that while the 6-month-old cohort showed no significant differences between nicotine-treated and control groups regardless of genotype, nicotine improved contextual fear memory in 11-month- old DKO mice but impaired nest-building ability and cued fear memory in age-matched WT controls. Transcriptome analysis of the prefrontal cortex identified distinct molecular responses to nicotine between genotypes. Results: In DKO mice, nicotine modulated neuropeptide signaling and reduced astrocyte activation, while in WT mice, it disrupted cytokine-cytokine receptor interaction and neuroactive ligand- receptor interaction pathways. Western blot analysis revealed that nicotine treatment significantly reduced tau hyperphosphorylation and Glial Fibrillary Acidic Protein (GFAP) expression in 11-month-old DKO mice, which was further confirmed by immunohistochemistry showing decreased astrocyte activation in multiple brain regions. Conclusion: These findings demonstrate that nicotine's effects on cognition and molecular pathways are both age- and genotype-dependent, suggesting its therapeutic potential may be limited to specific stages of neurodegeneration while potentially having adverse effects in healthy aging brains.

5 November 2026 in medRxiv
Verified
Preprint
Open access
PDF file
YSYouwei Si
Youwei Si
YSYouwen Si
Youwen Si
Objective: To integrate single-cell expression quantitative trait locus (sc-eQTL), Alzheimer’s disease (AD) genome-wide association study (GWAS), and Bayesian colocalization analyses, in order to systematically identify candidate causal genes and potential immune mechanisms that specifically regulate AD risk in peripheral immune cells. Methods: Using the cis-eQTLs of 14 peripheral blood immune cell types from the OneK1K single-cell eQTL dataset as exposure data and the AD GWAS (GCST90565439) as outcome data, a two-sample Mendelian randomization (MR) analysis was performed. Weak instrumental variables were removed using F-statistics, and approximately independent genetic instruments were obtained by linkage disequilibrium pruning. For significant gene–cell type associations, compareCluster functional enrichment, Bayesian colocalization, and phenome-wide association study (PheWAS) were further performed, and the 1M-scBloodNL dataset was used for replication validation. Results: The MR analysis identified 187 gene–cell type associations significantly associated with AD risk, involving 161 candidate causal genes. Among them, 141 genes showed significant associations in only a single immune cell type, suggesting that AD-related immune genetic regulation has marked cell type specificity. Functional enrichment analysis showed that the significant genes in different immune cell types were enriched in biological processes including MHC class II antigen presentation, phagocytosis, membrane invagination, and positive regulation of T cell activation. Colocalization analysis indicated a strong shared genetic signal between TNF expression in CD4+SOX4+ T cells and AD risk (PP.H4 = 0.833). In the 1M-scBloodNL replication analysis, several candidate genes showed consistent direction and nominal significance. The PheWAS results suggested that the significant phenotypic associations of the TNF instrumental variable were mainly concentrated in immune- and hematology-related traits, with no genome-wide significant neurological phenotypic associations observed. Conclusion: This study suggests that single-cell eQTL-MR combined with colocalization analysis can be used to dissect the cell type-specific genetic regulatory mechanisms of peripheral immunity in AD. The genetically predicted expression of TNF in CD4+SOX4+ T cells may represent an important immune-related signal for AD risk, but further validation in independent populations and functional experiments is still required.

21 November 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
YSYouwen Si
Youwen Si
SQShuai Qiu
Shuai Qiu
LWLina Wang
Lina Wang
BMBo Meng
Bo Meng
FQFeiyan Qi
Feiyan Qi
Nicotine, a primary bioactive compound in tobacco, influences a wide range of metabolic pathways, with potential implications for neurodegenerative diseases such as Alzheimer’s disease (AD). This study investigates the metabolic effects of chronic nicotine administration in presenilin-1/2 double knockout (DKO) mice and wild-type (WT) control mice. Eight-month-old DKO and WT mice underwent a three-month oral nicotine administration which did not significantly affect body weight or spontaneous locomotor activity in either DKO or WT mice, as measured by weekly body weight measurement and open field test. The metabolomic analyses were performed using untargeted LC-MS and GC-MS techniques. The results revealed distinct metabolic profiles between DKO and WT mice under nicotine exposure. In DKO mice, nicotine exacerbated deficits in purine and nicotinamide metabolism, further highlighting dysregulation in energy homeostasis. Key findings include reduced adenosine and elevated dopamine levels in DKO serum, alongside increased cotinine concentrations, suggesting altered nicotine metabolism. WT mice showed significant changes in energy and lipid metabolism pathways, though with less pronounced alterations compared to DKO mice. Enrichment analyses identified significant pathway disruptions, particularly in choline metabolism, amino acid metabolism, and central carbon metabolism, with genotype-dependent responses to nicotine. This study highlights the intrinsic metabolic alterations in DKO mice, such as disruptions in purine and nicotinamide metabolism, which contribute to their neurodegenerative pathology and unique responses to nicotine. By revealing the differential metabolic impacts of nicotine on healthy and neurodegenerative states, the findings provide valuable insights into its dual therapeutic and pathological roles. These results may guide future research into the metabolic underpinnings of neurodegeneration and the potential for nicotine as a targeted therapeutic intervention.